Allos, BM (2001). Campylobacter jejuni infections: update on emerging issues and trends. Clinical Infectious Diseases 32: 1201–1206.
Almofti, YA, Dai, M, Sun, Y, Hao, H, Liu, Z, Cheng, G and Yuan, Z (2011). The physiologic and phenotypic alterations due to macrolide exposure in Campylobacter jejuni. International Journal of Food Microbiology 151: 52–61.
Altekruse, SF, Stern, NJ, Fields, PI and Swerdlow, DL (1999). Campylobacter jejuni--an emerging foodborne pathogen. Emerging Infectious Diseases 5: 28–35.
Amar, C, Kittl, S, Spreng, D, Thomann, A, Korczak, BM, Burnens, AP and Kuhnert, P (2014). Genotypes and antibiotic resistance of canine Campylobacter jejuni isolates. Veterinary Microbiology 168: 124–130.
Archelos, JJ, Fortwangler, T and Hartung, HP (1997). Attenuation of experimental autoimmune neuritis in the Lewis rat by treatment with an antibody to L-selectin. Neuroscience Letters 235: 9–12.
Bell, JA, St Charles, JL, Murphy, AJ, Rathinam, VA, Plovanich-Jones, AE, Stanley, EL, Wolf, JE, Gettings, JR, Whittam, TS and Mansfield, LS (2009). Multiple factors interact to produce responses resembling spectrum of human disease in Campylobacter jejuni infected C57BL/6 IL-10-/- mice. BMC Microbiology 9: 57.
Bell, JA, Jerome, JP, Plovanich-Jones, AE, Smith, EJ, Gettings, JR, Kim, HY, Landgraf, JR, Lefébure, T, Kopper, JJ, Rathinam, VA, Charles, JLS, Buffa, BA, Brooks, AP, Poe, SA, Eaton, KA, Stanhope, MJ and Mansfield, LS (2013a). Outcome of infection of C57BL/6 IL-10−/− mice with Campylobacter jejuni strains is correlated with genome content of open reading frames up- and down-regulated in vivo. Microbial Pathogenesis 54: 119.
Bell, JA, Jerome, JP, Plovanich-Jones, AE, Smith, EJ, Gettings, JR, Kim, HY, Landgraf, JR, Lefebure, T, Kopper, JJ, Rathinam, VA, St Charles, JL, Buffa, BA, Brooks, AP, Poe, SA, Eaton, KA, Stanhope, MJ and Mansfield, LS (2013b). Outcome of infection of C57BL/6 IL-10(−/−) mice with Campylobacter jejuni strains is correlated with genome content of open reading frames up- and down-regulated in vivo. Microbial Pathogenesis 54: 1–19.
Bereswill, S, Fischer, A, Plickert, R, Haag, LM, Otto, B, Kühl, AA, Dasti, JI, Zautner, AE, Muñoz, M, Loddenkemper, C, Gross, U, Göbel, UB and Heimesaat, MM (2011). Novel murine infection models provide deep insights into the “ménage à trois” of Campylobacter jejuni, microbiota and host innate immunity. PLoS ONE 6: e20953.
Blaser, MJ, Glass, RI, Hug, MI, Stoll, B, Kibrya, GM and Alim, ARMA (1980). Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. Journal of Clinical Microbiology 12: 744–747.
Bopp, DJ, Sauders, BD, Waring, AL, Ackelsberg, J, Dumas, N, Braun-Howland, E, Dziewulski, D, Wallace, BJ, Kelly, M, Halse, T, Musser, KA, Smith, PF, Morse, DL and Limberger, RJ (2003). Detection, isolation, and molecular subtyping of Escherichia coli O157:H7 and Campylobacter jejuni associated with a large waterborne outbreak. Journal of Clinical Microbiology 41: 174–180.
Brooks, PT, Brakel, KA, Bell, JA, Bejcek, CE, Gilpin, T, Brudvig, JM and Mansfield, LS (2017). Transplanted human fecal microbiota enhanced Guillain Barre syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice. Microbiome 5: 92.
Bruce, D, Zochowski, W and Fleming, GA (1980). Campylobacter infections in cats and dogs. The Veterinary Record 107: 200–201.
Buffie, CG and Pamer, EG (2013). Microbiota-mediated colonization resistance against intestinal pathogens. Nature Reviews Immunology 13: 790–801.
Cagliero, C, Cloix, L, Cloeckaert, A and Payot, S (2006). High genetic variation in the multidrug transporter cmeB gene in Campylobacter jejuni and Campylobacter coli. Journal of Antimicrobial Chemotherapy 58: 168–172.
Caldwell, MB, Guerry, P, Lee, EC, Burans, JP and Walker, RI (1985). Reversible expression of flagella in Campylobacter jejuni. Infection and Immunity 50: 941–943.
Cawthraw, SA, Wassenaar, TM, Ayling, R and Newell, DG (1996). Increased colonization potential of Campylobacter jejuni strain 81116 after passage through chickens and its implication on the rate of transmission within flocks. Epidemiology and Infection 117: 213–215.
Cawthraw, SA, Feldman, RA, Sayers, AR and Newell, DG (2002). Long-term antibody responses following human infection with Campylobacter jejuni. Clinical and Experimental Immunology 130: 101–106.
CDC (2011). Vital signs: incidence and trends of infection with pathogens transmitted commonly through food--foodborne diseases active surveillance network, 10 U.S. Sites, 1996–2010. MMWR. Morbidity and Mortality Weekly Report 60: 749–755.
CDC (2013). Antibiotic Resistance Threats in the United States, 2013. . Atlanta, GA: U.S. Department of Health and Human Services, pp. 1–114.
CDC (2017). National Antimicrobial Resistance Monitoring System (NARMS) Now: Human Data. Atlanta, Georgia: U.S. Department of Health and Human Services, C.
Cha, W, Mosci, RE, Wengert, SL, Venegas Vargas, C, Rust, SR, Bartlett, PC, Grooms, DL and Manning, SD (2017). Comparing the genetic diversity and antimicrobial resistance profiles of Campylobacter jejuni recovered from cattle and humans. Frontiers in Microbiology 8: 818.
Chaban, B, Ngeleka, M and Hill, JE (2010). Detection and quantification of 14 Campylobacter species in pet dogs reveals an increase in species richness in feces of diarrheic animals. BMC Microbiology 10: 73.
Chang, C and Miller, JF (2006). Campylobacter jejuni colonization of mice with limited enteric flora. Infection and Immunity 74: 52615271.
Chervonsky, AV (2013). Microbiota and autoimmunity. Cold Spring Harbor Perspectives in Biology 5: a007294.
de Boer, P, Wagenaar, JA, Achterberg, RP, van Putten, JP, Schouls, LM and Duim, B (2002). Generation of Campylobacter jejuni genetic diversity in vivo. Molecular Microbiology 44: 351–359.
Ercolini, AM and Miller, SD (2009). The role of infections in autoimmune disease. Clinical and Experimental Immunology 155: 1–15.
Farmer, RG (1990). Infectious causes of diarrhea in the differential diagnosis of inflammatory bowel disease. The Medical Clinics of North America 74: 29–38.
FDA (2014). FDA Releases 2014 NARMS Integrated Report; Finds Measurable Improvements in Antimicrobial Resistance Levels. Medicine, C.f.V. (ed.). Rockville, MD.
Fearnhead, P, Smith, NG, Barrigas, M, Fox, A and French, N (2005). Analysis of recombination in Campylobacter jejuni from MLST population data. Journal of Molecular Evolution 61: 333–340.
Fernandez-Cruz, A, Munoz, P, Mohedano, R, Valerio, M, Marin, M, Alcala, L, Rodriguez-Creixems, M, Cercenado, E and Bouza, E (2010). Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years. Medicine 89: 319–330.
Fitzgeorge, RB, Baskerville, A and Lander, KP (1981). Experimental infection of rhesus monkeys with a human strain of Campylobacter jejuni. The Journal of Hygiene 86: 343–351.
Fox, JG (1992). In vivo models of enteric campylobacteriosis: natural and experimental infections. In: Nachamkin, I, Blaser, MJ, Tompkins, LS (eds) Campylobacter Jejuni: Current Status and Future Trends. Washington, DC: ASM Press, pp. 131–138.
Fox, JG, Moore, R and Ackerman, JI (1983). Campylobacter-Jejuni-Associated diarrhea in dogs. Journal of the American Veterinary Medical Association 183: 1430–1433.
Fox, JG, Rogers, AB, Whary, MT, Ge, Z, Taylor, NS, Xu, S, Horwitz, BH and Erdman, SE (2004). Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infection and Immunity 72: 1116–1125.
Garcia Rodriguez, LA, Ruigomez, A and Panes, J (2006). Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 130: 1588–1594.
Gilbert, M, Karwaski, MF, Bernatchez, S, Young, NM, Taboada, E, Michniewicz, J, Cunningham, AM and Wakarchuk, WW (2002). The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. Journal of Biological Chemistry 277: 327–337.
Gilbert, M, Godschalk, PC, Karwaski, MF, Ang, CW, van Belkum, A, Li, J, Wakarchuk, WW and Endtz, HP (2004). Evidence for acquisition of the lipooligosaccharide biosynthesis locus in Campylobacter jejuni GB11, a strain isolated from a patient with Guillain-Barré syndrome, by horizontal exchange. Infection and Immunity 72: 1162–1165.
Godschalk, PC, Heikema, AP, Gilbert, M, Komagamine, T, Ang, CW, Glerum, J, Brochu, D, Li, J, Yuki, N, Jacobs, BC, van Belkum, A and Endtz, HP (2004). The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome. The Journal of Clinical Investigation 114: 1659–1665.
Godschalk, PC, Bergman, MP, Gorkink, RF, Simons, G, van den Braak, N, Lastovica, AJ, Endtz, HP, Verbrugh, HA and van Belkum, A (2006). Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barre syndrome by high-throughput AFLP analysis. BMC Microbiology 6: 32.
Godschalk, PC, Kuijf, ML, Li, J, St Michael, F, Ang, CW, Jacobs, BC, Karwaski, MF, Brochu, D, Moterassed, A, Endtz, HP, van Belkum, A and Gilbert, M (2007). Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and miller fisher syndromes. Infection and Immunity 75: 1245–1254.
Guerry, P, Szymanski, CM, Prendergast, MM, Hickey, TE, Ewing, CP, Pattarini, DL and Moran, AP (2002). Phase variation of Campylobacter jejuni 81–176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infection and Immunity 70: 787–793.
Halbert, LW, Kaneene, JB, Linz, J, Mansfield, LS, Wilson, D, Ruegg, PL, Warnick, LD, Wells, SJ, Fossler, CP, Campbell, AM and Geiger-Zwald, AM (2006). Genetic mechanisms contributing to reduced tetracycline susceptibility of campylobacter isolated from organic and conventional dairy farms in the midwestern and northeastern United States. Journal of Food Protection 69: 482–488.
Hermans, D, Pasmans, F, Heyndrickx, M, Van Immerseel, F, Martel, A, Van Deun, K and Haesebrouck, F (2012). A tolerogenic mucosal immune response leads to persistent Campylobacter jejuni colonization in the chicken gut. Critical Reviews in Microbiology 38: 17–29.
Hill, GA and Grimes, DJ (1984). Seasonal study of a freshwater lake and migratory waterfowl for Campylobacter jejuni. Canadian journal of Microbiology 30: 845–849.
Hold, GL, Smith, M, Grange, C, Watt, ER, El-Omar, EM and Mukhopadhya, I (2014). Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World Journal of Gastroenterology 20: 1192–1210.
Holmes, AH, Moore, LS, Sundsfjord, A, Steinbakk, M, Regmi, S, Karkey, A, Guerin, PJ and Piddock, LJ (2016). Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387: 176–187.
Honda, K and Littman, DR (2012). The microbiome in infectious disease and inflammation. Annual Review of Immunology 30: 759–795.
Horwitz, MA and Silverstein, SC (1980). Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. The Journal of Clinical Investigation 65: 82–94.
Humphrey, S, Chaloner, G, Kemmett, K, Davidson, N, Williams, N, Kipar, A, Humphrey, T and Wigley, P (2014). Campylobacter jejuni is not merely a commensal in commercial broiler chickens and affects bird welfare. MBio 5: e01364–e01314.
Hurd, HS, Vaughn, MB, Holtkamp, D, Dickson, J and Warnick, L (2010). Quantitative risk from fluoroquinolone-resistant Salmonella and Campylobacter due to treatment of dairy heifers with enrofloxacin for bovine respiratory disease. Foodborne Pathogens and Disease 7: 1305–1322.
Jackson, BR, Zegarra, JA, Lopez-Gatell, H, Sejvar, J, Arzate, F, Waterman, S, Nunez, AS, Lopez, B, Weiss, J, Cruz, RQ, Murrieta, DY, Luna-Gierke, R, Heiman, K, Vieira, AR, Fitzgerald, C, Kwan, P, Zarate-Bermudez, M, Talkington, D, Hill, VR and Mahon, B, Team GBSOI (2014). Binational outbreak of Guillain-Barre syndrome associated with Campylobacter jejuni infection, Mexico and USA, 2011. Epidemiology and Infection 142: 1089–1099.
Janssen, R, Krogfelt, KA, Cawthraw, SA, van Pelt, W, Wagenaar, JA and Owen, RJ (2008). Host-pathogen interactions in Campylobacter infections: the host perspective. Clinical Microbiology Reviews 21: 505–518.
Jerome, JP, Bell, JA, Plovanich-Jones, AE, Barrick, JE, Brown, CT and Mansfield, LS (2011). Standing genetic variation in contingency loci drives the rapid adaptation of Campylobacter jejuni to a novel host. PLoS ONE 6: e16399.
Johnson, TJ, Shank, JM and Johnson, JG (2017). Current and potential treatments for reducing campylobacter colonization in animal hosts and disease in humans. Frontiers in Microbiology 8: 487–000.
Jones, MA, Marston, KL, Woodall, CA, Maskell, DJ, Linton, D, Karlyshev, AV, Dorrell, N, Wren, BW and Barrow, PA (2004). Adaptation of Campylobacter jejuni NCTC11168 to high-level colonization of the avian gastrointestinal tract. Infection and Immunity 72: 37693776.
Kaakoush, NO, Castano-Rodriguez, N, Mitchell, HM and Man, SM (2015). Global epidemiology of campylobacter infection. Clinical microbiology reviews 28: 687–720.
Kaida, K and Kusunoki, S (2010). Antibodies to gangliosides and ganglioside complexes in Guillain-Barre syndrome and Fisher syndrome: mini-review. Journal of Neuroimmunology 223: 5–12.
Karmali, MA and Fleming, PC (1979). Campylobacter enteritis in children. Journal of Pediatrics 94: 527–533.
Keithlin, J, Sargeant, J, Thomas, MK and Fazil, A (2014). Systematic review and meta-analysis of the proportion of Campylobacter cases that develop chronic sequelae. BMC Public Health 14: 1203.
Ketley, J, Guerry, P and Panigrahi, P (1996). Pathogenic mechanisms. In: Newell, DG, Ketley, JM, Feldman, RA (eds) Campylobacters, Helicobacters, and Related Organisms. New York: Plenum Press, pp. 537–544.
Ketley, JM (1997). Pathogenesis of enteric infection by Campylobacter. Microbiology 143(Pt 1): 5–21.
Kim, JS, Artymovich, KA, Hall, DF, Smith, EJ, Fulton, R, Bell, J, Dybas, L, Mansfield, LS, Tempelman, R, Wilson, DL and Linz, JE (2012). Passage of Campylobacter jejuni through the chicken reservoir or mice promotes phase variation in contingency genes Cj0045 and Cj0170 that strongly associates with colonization and disease in a mouse model. Microbiology 158: 1304–1316.
Kivistö, RI, Kovanen, S, Skarp-de Haan, A, Schott, T, Rahkio, M, Rossi, M and Hänninen, ML (2014). Evolution and comparative genomics of Campylobacter jejuni ST-677 clonal complex. Genome Biol Evol 6: 2424–2438.
Klancnik, A, Mozina, SS and Zhang, Q (2012). Anti-Campylobacter activities and resistance mechanisms of natural phenolic compounds in Campylobacter. PLoS ONE 7: e51800.
Knudsen, KN, Bang, DD, Nielsen, EM and Madsen, M (2005). Genotyping of Campylobacter jejuni strains from Danish broiler chickens by restriction fragment length polymorphism of the LPS gene cluster. Journal of Applied Microbiology 99: 392–399.
Koga, M, Takahashi, M, Masuda, M, Hirata, K and Yuki, N (2005). Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barre syndrome. Neurology 65: 1376–1381.
Kurz, M, Pischel, H, Hartung, HP and Kieseier, BC (2005). Tumor necrosis factor-alpha-converting enzyme is expressed in the inflamed peripheral nervous system. Journal of the Peripheral Nervous System 10: 311–318.
Landers, TF, Cohen, B, Wittum, TE and Larson, EL (2012). A review of antibiotic use in food animals: perspective, policy, and potential. Public Health Reports 127: 4–22.
Lehmann, HC, Lopez, PH, Zhang, G, Ngyuen, T, Zhang, J, Kieseier, BC, Mori, S and Sheikh, KA (2007). Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model. Journal of Neuroscience 27: 27–34.
Li, CY, Xue, P, Tian, WQ, Liu, RC and Yang, C (1996). Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barre syndrome. Journal of Neurology, Neurosurgery, and Psychiatry 61: 279–284.
Linton, D, Gilbert, M, Hitchen, PG, Dell, A, Morris, HR, Wakarchuk, WW, Gregson, NA and Wren, BW (2000). Phase variation of a beta-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni. Molecular Microbiology 37: 501–514.
Luangtongkum, T, Shen, Z, Seng, VW, Sahin, O, Jeon, B, Liu, P and Zhang, Q (2012). Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host. Antimicrobial Agents and Chemotherapy 56: 1300–1308.
Luo, N, Pereira, S, Sahin, O, Lin, J, Huang, S, Michel, L and Zhang, Q (2005). Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proceedings of the National Academy of Sciences of the United States of America 102: 541–546.
Malik, A, Sharma, D, St Charles, J, Dybas, LA and Mansfield, LS (2014). Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity. Mucosal Immunology 7: 802–817.
Mansfield, LS and Urban, JF (1996). The pathogenesis of necrotic proliferative colitis in swine is linked to whipworm induced suppression of mucosal immunity to resident bacteria. Veterinary Immunology and Immunopathology 50: 1–17.
Mansfield, LS, Bell, JA, Wilson, DL, Murphy, AJ, Elsheikha, HM, Rathinam, VA, Fierro, BR, Linz, JE and Young, VB (2007). C57BL/6 and congenic interleukin-10-deficient mice can serve as models of Campylobacter jejuni colonization and enteritis. Infection and Immunity 75: 1099–1115.
Mansfield, LS, Patterson, JS, Fierro, BR, Murphy, AJ, Rathinam, VA, Kopper, JJ, Barbu, NI, Onifade, TJ and Bell, JA (2008a). Genetic background of IL-10(−/−) mice alters host-pathogen interactions with Campylobacter jejuni and influences disease phenotype. Microbial Pathogenesis 45: 241–257.
Mansfield, LS, Schauer, DB and Fox, JG (2008b). Chapter 21: animal models of Campylobacter jejuni infections. In: Nachamkin, I, Szymanski, CM, Blaser, MJ (eds) Campylobacter. Washington, DC: American Society for Microbiology Press, pp. 376–379.
Martini, R and Willison, H (2016). Neuroinflammation in the peripheral nerve: cause, modulator, or bystander in peripheral neuropathies? Glia 64: 475–486.
Maruyama, S, Tanaka, T, Katsube, Y, Nakanishi, H and Nukina, M (1990). Prevalence of thermophilic Campylobacters in crows (Corvus levaillantii, Corvus corone) and serogroups of the isolates. Nippon Juigaku Zasshi 52: 1237–1244.
McCrackin, MA, Helke, KL, Galloway, AM, Poole, AZ, Salgado, CD and Marriott, BP (2016). Effect of antimicrobial use in agricultural animals on drug-resistant foodborne campylobacteriosis in humans: a systematic literature review. Critical Reviews in Food Science and Nutrition 56: 2115–2132.
McGonigal, R, Rowan, EG, Greenshields, KN, Halstead, SK, Humphreys, PD, Rother, RP, Furukawa, K and Willison, HJ (2010). Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of ranvier in mice. Brain 133: 1944–1960.
Mohawk, KL, Poly, F, Sahl, JW, Rasko, DA and Guerry, P (2014). High frequency, spontaneous motA mutations in Campylobacter jejuni strain 81–176. PLoS ONE 9: e88043.
Montrose, MS, Shane, SM and Harrington, KS (1985). Role of litter in the transmission of Campylobacter jejuni. Avian Diseases 29: 392–399.
Moore, JE, Barton, MD, Blair, IS, Corcoran, D, Dooley, JS, Fanning, S, Kempf, I, Lastovica, AJ, Lowery, CJ, Matsuda, M, McDowell, DA, McMahon, A, Millar, BC, Rao, JR, Rooney, PJ, Seal, BS, Snelling, WJ and Tolba, O (2006). The epidemiology of antibiotic resistance in Campylobacter. Microbes and Infection/Institut Pasteur 8: 1955–1966.
Moore, KW, Malefyt, RD, Coffman, RL and O'Garra, A (2001). Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 19: 683–765.
Moxon, ER, Paul, BR, Martin, AN and Richard, EL (1994). Adaptive evolution of highly mutable loci in pathogenic bacteria. Current Biology 4: 2433.
Nachamkin, I, Yang, XH and Stern, NJ (1993). Role of Campylobacter jejuni flagella as colonization factors for three-day-old chicks: analysis with flagellar mutants. Applied and Environmental Microbiology 59: 1269–1273.
Nachamkin, I, Allos, BM and Ho, T (1998). Campylobacter species and Guillain-Barre syndrome. Clinical Microbiology Reviews 11: 555–567.
Nachamkin, I, Liu, J, Li, M, Ung, H, Moran, AP, Prendergast, MM and Sheikh, K (2002). Campylobacter jejuni from patients with Guillain-Barre syndrome preferentially expresses a GD(1a)-like epitope. Infection and Immunity 70: 5299–5303.
Newell, DG (2001). Animal models of Campylobacter jejuni colonization and disease and the lessons to be learned from similar Helicobacter pylori models. Journal of Applied Microbiology 90: 57S–67S.
Newell, DG, Elvers, KT, Dopfer, D, Hansson, I, Jones, P, James, S, Gittins, J, Stern, NJ, Davies, R, Connerton, I, Pearson, D, Salvat, G and Allen, VM (2011). Biosecurity-based interventions and strategies to reduce Campylobacter spp. on poultry farms. Applied and Environmental Microbiology 77: 8605–8614.
Nuijten, PJM, Berg, AJGvd, Formentini, I, Zeijst, Mvd and Jacobs, AAC (2000). DNA rearrangements in the flagellin locus of an flaA mutant of Campylobacter jejuni during colonization of chicken ceca. Infection and Immunity 68: 71377140.
Nurieva, RI and Chung, Y (2010). Understanding the development and function of T follicular helper cells. Cellular & Molecular Immunology 7: 190–197.
O'Loughlin, JL, Samuelson, DR, Braundmeier-Fleming, AG, White, BA, Haldorson, GJ, Stone, JB, Lessmann, JJ, Eucker, TP and Konkel, ME (2015). The intestinal microbiota influences Campylobacter jejuni colonization and extraintestinal dissemination in mice. Applied and Environmental Microbiology 81: 4642–4650.
Oh, E and Jeon, B (2015). Synergistic anti-Campylobacter jejuni activity of fluoroquinolone and macrolide antibiotics with phenolic compounds. Frontiers in Microbiology 6: 1129.
Oh, SJ, LaGanke, C and Claussen, GC (2001). Sensory Guillain-Barre syndrome. Neurology 56: 82–86.
Oliver, SP, Patel, DA, Callaway, TR and Torrence, ME (2009). ASAS centennial paper: developments and future outlook for preharvest food safety. Journal of Animal Science 87: 419–437.
Ouyang, W, Rutz, S, Crellin, NK, Valdez, PA and Hymowitz, SG (2011). Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annual Review of Immunology 29: 71–109.
Parker, CT, Horn, ST, Gilbert, M, Miller, WG, Woodward, DL and Mandrell, RE (2005). Comparison of Campylobacter jejuni lipooligosaccharide biosynthesis loci from a variety of sources. Journal of Clinical Microbiology 43: 2771–2781.
Parkhill, J, Wren, BW, Mungall, K, Ketley, JM, Churcher, C, Basham, D, Chillingworth, T, Davies, RM, Feltwell, T, Holroyd, S, Jagels, K, Karlyshev, AV, Moule, S, Pallen, MJ, Penn, CW, Quail, MA, Rajandream, MA, Rutherford, KM, van Vliet, AH, Whitehead, S and Barrell, BG (2000). The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403: 665–668.
Pearson, AD, Greenwood, M, Healing, TD, Rollins, D, Shahamat, M, Donaldson, J and Colwell, RR (1993). Colonization of broiler chickens by waterborne Campylobacter jejuni. Applied and Environmental Microbiology 59: 987–996.
Perkins, DJ and Newstead, GL (1994). Campylobacter jejuni enterocolitis causing peritonitis, ileitis and intestinal obstruction. The Australian and New Zealand Journal of Surgery 64: 55–58.
Phongsisay, V, Perera, VN and Fry, BN (2006). Exchange of lipooligosaccharide synthesis genes creates potential Guillain-Barre syndrome-inducible strains of Campylobacter jejuni. Infection and Immunity 74: 1368–1372.
Pickett, CL, Pesci, EC, Cottle, DL, Russell, G, Erdem, AN and Zeytin, H (1996). Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene. Infection and Immunity 64: 2070–2078.
Prendergast, MM, Tribble, DR, Baqar, S, Scott, DA, Ferris, JA, Walker, RI and Moran, AP (2004). In vivo phase variation and serologic response to lipooligosaccharide of Campylobacter jejuni in experimental human infection. Infection and Immunity 72: 916–922.
Rathinam, VA, Hoag, KA and Mansfield, LS (2008). Dendritic cells from C57BL/6 mice undergo activation and induce Th1-effector cell responses against Campylobacter jejuni. Microbes and Infection 10: 1316–1324.
Rathinam, VA, Appledorn, DM, Hoag, KA, Amalfitano, A and Mansfield, LS (2009). Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through TLR4-MyD88 and TLR4-TRIF axes. Infection and Immunity 77: 2499–2507.
Sahin, O, Plummer, PJ, Jordan, DM, Sulaj, K, Pereira, S, Robbe-Austerman, S, Wang, L, Yaeger, MJ, Hoffman, LJ and Zhang, Q (2008). Emergence of a tetracycline-resistant Campylobacter jejuni clone associated with outbreaks of ovine abortion in the United States. Journal of Clinical Microbiology 46: 1663–1671.
Sahin, O, Fitzgerald, C, Stroika, S, Zhao, S, Sippy, RJ, Kwan, P, Plummer, PJ, Han, J, Yaeger, MJ and Zhang, Q (2012). Molecular evidence for zoonotic transmission of an emergent, highly pathogenic Campylobacter jejuni clone in the United States. Journal of Clinical Microbiology 50: 680–687.
Scallan, E, Hoekstra, RM, Angulo, FJ, Tauxe, RV, Widdowson, MA, Roy, SL, Jones, JL and Griffin, PM (2011). Foodborne illness acquired in the United States--major pathogens. Emerging Infectious Diseases 17: 7–15.
Scott, AE, Timms, AR, Connerton, PL, Loc Carrillo, C, Adzfa Radzum, K and Connerton, IF (2007). Genome dynamics of Campylobacter jejuni in response to bacteriophage predation. PLoS Pathogens 3: e119.
Sestak, K, Merritt, CK, Borda, J, Saylor, E, Schwamberger, SR, Cogswell, F, Didier, ES, Didier, PJ, Plauche, G, Bohm, RP, Aye, PP, Alexa, P, Ward, RL and Lackner, AA (2003). Infectious agent and immune response characteristics of chronic enterocolitis in captive rhesus macaques. Infection and Immunity 71: 4079–4086.
Shimon, S (2000). Animal models of autoimmunity and their relevance to human diseases. Current Opinion in Immunology 12: 684690.
Shin, R, Suzuki, M and Morishita, Y (2002). Influence of intestinal anaerobes and organic acids on the growth of enterohaemorrhagic Escherichia coli O157:H7. Journal of Medical Microbiology 51: 201–206.
Stahl, M, Ries, J, Vermeulen, J, Yang, H, Sham, HP, Crowley, SM, Badayeva, Y, Turvey, SE, Gaynor, EC, Li, X and Vallance, BA (2014). A novel mouse model of Campylobacter jejuni gastroenteritis reveals Key Pro-inflammatory and tissue protective roles for toll-like receptor signaling during infection. PLoS Pathogens 10: e1004264.
St Charles, JL, Bell, JA, Gadsden, BJ, Malik, A, Cooke, H, Van de Grift, LK, Kim, HY, Smith, EJ and Mansfield, LS (2017). Guillain Barre syndrome is induced in Non-obese diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics. Journal of Autoimmunity 77: 11–38.
Stecher, B and Hardt, WD (2008). The role of microbiota in infectious disease. Trends in Microbiology 16: 107–114.
Suerbaum, S, Lohrengel, M, Sonnevend, A, Ruberg, F and Kist, M (2001). Allelic diversity and recombination in Campylobacter jejuni. Journal of Bacteriology 183: 2553–2559.
Tadesse, DA, Bahnson, PB, Funk, JA, Thakur, S, Morrow, WE, Wittum, T, DeGraves, F, Rajala-Schultz, P and Gebreyes, WA (2011). Prevalence and antimicrobial resistance profile of Campylobacter spp. Isolated from conventional and antimicrobial-free swine production systems from different U.S. Regions. Foodborne Pathogens and Disease 8: 367–374.
Tam, CC, O'Brien, SJ, Petersen, I, Islam, A, Hayward, A and Rodrigues, LC (2007). Guillain-Barre syndrome and preceding infection with Campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS ONE 2: e344.
Ternhag, A, Torner, A, Svensson, A, Ekdahl, K and Giesecke, J (2008). Short- and long-term effects of bacterial gastrointestinal infections. Emerging Infectious Diseases 14: 143–148.
Thomas, DK, Lone, AG, Selinger, LB, Taboada, EN, Uwiera, RR, Abbott, DW and Inglis, GD (2014). Comparative variation within the genome of Campylobacter jejuni NCTC 11168 in human and murine hosts. PLoS ONE 9: e88229.
Vandenberg, O, Cornelius, AJ, Souayah, H, Martiny, D, Vlaes, L, Brandt, SM and On, SL (2013). The role of Epsilonproteobacteria in children with gastroenteritis. The Pediatric Infectious Disease Journal 32: 1140–1142.
van den Berg, B, Walgaard, C, Drenthen, J, Fokke, C, Jacobs, BC and van Doorn, PA (2014). Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nature Reviews Neurology 10: 469–482.
van der Waaij, D, Berghuis-de Vries, JM and Lekkerkerk-van der Wees, JEC (1971). Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. The Journal of Hygiene (Lond) 69: 405–411.
van der Waaij, D, Berghuis-de Vries, JM and Lekkerkerk-van der Wees, JEC (1972). Colonization resistance of the digestive tract and the spread of bacteria to the lymphatic organs in mice. The Journal of Hygiene (Lond) 70: 335–342.
van der Woude, MW and Baumler, AJ (2004). Phase and antigenic variation in bacteria. Clinical Microbiology Reviews 17: 581–611.
Wassenaar, TM, Zeijst, BAMvd, Ayling, R and Newell, DG (1993). Colonization of chicks by motility mutants of Campylobacter jejuni demonstrates the importance of flagellin A expression. Journal of General Microbiology 139: 1171–1175.
Wassenaar, TM, Geilhausen, B and Newell, DG (1998). Evidence of genomic instability in Campylobacter jejuni isolated from poultry. Applied and environmental microbiology 64: 1816–1821.
Weis, AM, Storey, DB, Taff, CC, Townsend, AK, Huang, BC, Kong, NT, Clothier, KA, Spinner, A, Byrne, BA and Weimer, BC (2016). Genomic comparison of Campylobacter spp. and their potential for zoonotic transmission between birds, primates, and livestock. Applied and Environmental Microbiology 82: 7165–7175.
Wells, CL, Maddaus, MA, Jechorek, RP and Simmons, RL (1988). Role of intestinal anaerobic bacteria in colonization resistance. European Journal of Clinical Microbiology & Infectious Diseases 7: 107–113.
Willison, HJ and Plomp, JJ (2008). Anti-ganglioside antibodies and the presynaptic motor nerve terminal. Annals of the New York Academy of Sciences 1132: 114–123.
Willison, HJ, Jacobs, BC and van Doorn, PA (2016). Guillain-Barre syndrome. Lancet 388: 717–727.
Winter, SE, Thiennimitr, P, Winter, MG, Butler, BP, Huseby, DL, Crawford, RW, Russell, JM, Bevins, CL, Adams, LG, Tsolis, RM, Roth, JR and Bäumler, AJ (2010). Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467: 426–429.
Young, KT, Davis, LM and Dirita, VJ (2007). Campylobacter jejuni: molecular biology and pathogenesis. Nature Reviews. Microbiology 5: 665–679.
Young, VB and Mansfield, LS (2005). Campylobacter infection—clinical context. In: Ketley, JM, Konkel, ME (eds) Campylobacter: Molecular and Cellular Biology. London, UK: Horizon Bioscience, pp. 1–12.
Yuki, N, Taki, T, Inagaki, F, Kasama, T, Takahashi, M, Saito, K, Handa, S and Miyatake, T (1993). A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. The Journal of Experimental Medicine 178: 1771–1775.
Zhang, Q, Lin, J and Pereira, S (2003). Fluoroquinolone-resistant Campylobacter in animal reservoirs: dynamics of development, resistance mechanisms and ecological fitness. Animal Health Research Reviews 4: 63–71.
Zhang, Q, Sahin, O, McDermott, PF and Payot, S (2006). Fitness of antimicrobial-resistant Campylobacter and salmonella. Microbes and Infection 8: 1972–1978.
Zhou, K, Aertsen, A and Michiels, C (2014). The role of variable DNA tandem repeats in bacterial adaptation. FEMS Microbiology Reviews 38.